Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Kalmar Djursjukhus
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Kalmar Djursjukhus

June 18, 2012

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Kalmar Djursjukhus. Djursjukhusgruppen is Sweden’s leading group within expert veterinary care for dogs, cats and other pets. Djursjukhusgruppen consists of 18 veterinary surgeries and clinics throughout Sweden and has almost 500 employees and approximately 170 000 patients per year.

Vinge’s team consisted of, among others, Jonas Bergström, Gustav Jönsson, Johan Cederblad and Robin Dangoor.

Related

Vinge is advising Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135 million before deduction of transaction costs.
December 03, 2024

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

 Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.
December 02, 2024

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

 Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.
December 02, 2024